Mastercard Patented A Tool That Could Have Cracked This Summer's Cyclospora Outbreak. It Was Never Deployed
Finding the lettuce took days. Finding Taco Bell took two months. Mastercard patented a fix in 2014 and shelved it, chasing the wrong half of the problem.
- Mastercard filed a patent in 2014 for a payment-card-based food supply chain tracking system that could trace outbreak sources within days.
- The 2026 Cyclospora outbreak, linked to lettuce sold at Taco Bell, sickened over 400 people across 10 states and took two months to trace.
- Mastercard never developed or deployed the patented system, instead focusing on consumer analytics and fraud prevention technologies.
- The patent expired in 2024, leaving no active intellectual property protection for the concept, and no company has since commercialized it.
- CDC and FDA currently rely on manual receipt collection and patient interviews, leading to average trace times of 3–6 weeks for produce outbreaks.
Frequently Asked Questions
Mastercard patented a system in 2014 that would use anonymized payment card transaction data to trace the origin of contaminated food during an outbreak. It aimed to reduce trace times from weeks to days by analyzing where specific produce was sold.
Mastercard chose to focus its innovation budget on consumer loyalty programs and fraud detection instead of supply chain tracking. The company never built or tested the system, and the patent expired in 2024.
The CDC and FDA rely on manual interviews with patients to identify common food exposures and collect store receipts. This method can take months, as seen in the Taco Bell lettuce outbreak that required two months to link the illness to the restaurant chain.
The patent could have dramatically sped up identification of the contaminated product, potentially limiting the outbreak's spread. However, it would not have prevented the initial contamination, only faster detection.
No. Since Mastercard's patent expired, no company has commercialized a similar payment-card-based tracking system. Current efforts focus on blockchain and other voluntary supply chain tags.
It highlights a missed opportunity to leverage existing payment infrastructure for public health. Critics argue that corporate priorities undervalue life-saving applications of available data.
Topics
Original source
www.forbes.com
Discussion
Join the discussion
Sign in to post a comment or reply.
No comments yet. Be the first to share your thoughts!